Fábio Pitta1, Thierry Troosters1, Vanessa S Probst1, Daniel Langer1, Marc Decramer1, Rik Gosselink2. 1. Respiratory Rehabilitation and Respiratory Division, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. 2. Respiratory Rehabilitation and Respiratory Division, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. Electronic address: Rik.Gosselink@faber.kuleuven.be.
Abstract
BACKGROUND: Despite a variety of benefits brought by pulmonary rehabilitation to patients with COPD, it is unclear whether these patients are more active during daily life after the program. METHODS: Physical activities in daily life (activity monitoring), pulmonary function (spirometry), exercise capacity (incremental cycle-ergometer testing and 6-min walk distance testing), muscle force (quadriceps and handgrip force, and inspiratory and expiratory maximal pressures), quality of life (chronic respiratory disease questionnaire), and functional status (pulmonary functional status and dyspnea questionnaire-modified version) were assessed at baseline, after 3 months of a multidisciplinary rehabilitation program, and at the end of a 6-month multidisciplinary rehabilitation program in 29 patients (mean [+/- SD] age, 67 +/- 8 years; FEV(1), 46 +/- 16% predicted). RESULTS: Exercise capacity, muscle force, quality of life, and functional status improved significantly after 3 months of pulmonary rehabilitation (all p < 0.05), with further improvements in muscle force, functional status, and quality of life at 6 months. Movement intensity during walking improved significantly after 3 months (p = 0.046) with further improvements after 6 months (p = 0.0002). Walking time in daily life did not improve significantly at 3 months (mean improvement, 7 +/- 35%; p = 0.21), but only after 6 months (mean improvement, 20 +/- 36%; p = 0.008). No significant changes occurred in other activities or in the pattern of the time spent walking in daily life. Changes in dyspnea after the program were significantly related to changes in walking time in daily life (r = 0.43; p = 0.02). CONCLUSION: If one aims at changing physical activity habits in the daily life of COPD patients, the contribution of long-lasting programs might be important.
BACKGROUND: Despite a variety of benefits brought by pulmonary rehabilitation to patients with COPD, it is unclear whether these patients are more active during daily life after the program. METHODS: Physical activities in daily life (activity monitoring), pulmonary function (spirometry), exercise capacity (incremental cycle-ergometer testing and 6-min walk distance testing), muscle force (quadriceps and handgrip force, and inspiratory and expiratory maximal pressures), quality of life (chronic respiratory disease questionnaire), and functional status (pulmonary functional status and dyspnea questionnaire-modified version) were assessed at baseline, after 3 months of a multidisciplinary rehabilitation program, and at the end of a 6-month multidisciplinary rehabilitation program in 29 patients (mean [+/- SD] age, 67 +/- 8 years; FEV(1), 46 +/- 16% predicted). RESULTS: Exercise capacity, muscle force, quality of life, and functional status improved significantly after 3 months of pulmonary rehabilitation (all p < 0.05), with further improvements in muscle force, functional status, and quality of life at 6 months. Movement intensity during walking improved significantly after 3 months (p = 0.046) with further improvements after 6 months (p = 0.0002). Walking time in daily life did not improve significantly at 3 months (mean improvement, 7 +/- 35%; p = 0.21), but only after 6 months (mean improvement, 20 +/- 36%; p = 0.008). No significant changes occurred in other activities or in the pattern of the time spent walking in daily life. Changes in dyspnea after the program were significantly related to changes in walking time in daily life (r = 0.43; p = 0.02). CONCLUSION: If one aims at changing physical activity habits in the daily life of COPDpatients, the contribution of long-lasting programs might be important.
Authors: Marilyn L Moy; Riley J Collins; Carlos H Martinez; Reema Kadri; Pia Roman; Robert G Holleman; Hyungjin Myra Kim; Huong Q Nguyen; Miriam D Cohen; David E Goodrich; Nicholas D Giardino; Caroline R Richardson Journal: Chest Date: 2015-07 Impact factor: 9.410
Authors: Bruce G Bender; Ann Depew; Amanda Emmett; Kelly Goelz; Barry Make; Sanjay Sharma; Jennifer Underwood; David Stempel Journal: Chronic Obstr Pulm Dis Date: 2016-10-07
Authors: Carlos A Camillo; Fabio Pitta; Heloíse V Possani; Marcus V R A Barbosa; Divina S O Marques; Vinícius Cavalheri; Vanessa S Probst; Antonio F Brunetto Journal: Lung Date: 2008-09-25 Impact factor: 2.584
Authors: Marie-Kathrin Breyer; Robab Breyer-Kohansal; Georg-Christian Funk; Nicole Dornhofer; Martijn A Spruit; Emiel F M Wouters; Otto C Burghuber; Sylvia Hartl Journal: Respir Res Date: 2010-08-22